Apart from triumph in developing several potent drugs used in therapy for diabetes mellitus (DM) by shielding GLP-1 degradation, DPP-4 inhibitors could be much more beneficial in a broader spectrum of indications [4]. The gene discussed is GCG; the disease is diabetes mellitus.